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Introduction
Teratomas are the most common ovarian germ-cell neo-
plasm. They may be found in any combination of  mature 
and immature tissues exhibiting various histological cell 
types. The most common of  these is the mature cystic tera-
toma, also known as a dermoid cyst. These benign lesions 
typically contain mature tissues of  ectodermal, mesoder-
mal, and endodermal origins and must include well-
differentiated tissues from at least two of  these three germ-
cell layers. Mature cystic teratomas are among the most 
common ovarian masses found in children and are typically 
asymptomatic due to their slow growth rate. The gross ap-
pearance is characteristic, with the majority being lined 
with squamous-cell epithelium and filled with sebaceous 
material. Hair follicles, brain, teeth, and muscle tissue may 
all be present within the cyst (1). 
In rare cases, a single germ-cell layer may predominate, 
creating a monodermal teratoma and taking on the ap-
pearance, and sometimes functionality of  the specific histo-
logical cell type. While approximately 15% of  all teratomas 
contain a small, nonsignificant focus of  thyroid tissue, the 
definition of  struma ovarii is an ovarian tumor with thyroid 
tissue occupying greater than 50% of  the lesion (2). The 
gross appearance differs from a mature cystic teratoma, as 
it is often solid-cystic in architecture and may consist of  a 
mixture of  hemorrhagic, fibrotic, necrotic, and amber-
colored thyroid tissues (1,3). The majority of  these tumors 
are nonfunctional, and only 3% to 8% of  patients present 
with hyperthyroidism. Struma ovarii is most common in an 
older age group, with the majority of  cases occurring be-
tween ages 40 and 60 years (4). Women with struma ovarii 
may present with pelvic pain and/or an asymptomatic pel-
vic mass (3). For the majority of  patients, struma ovarii is 
benign and carries an excellent prognosis (5). 
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Struma ovarii is very uncommon, accounting for less 
than 3% of  all mature cystic ovarian teratomas (3). Pre-
operative diagnosis is difficult, because this rare tumor has 
no differentiating signs or symptoms (6,7). Imaging modali-
ties such as ultrasound, CT, MRI, and scintigraphy of  the 
pelvis can make the diagnosis when suspicion of  struma 
ovarii exists. Even with the availability of  these studies, to 
our knowledge only two other cases of  preoperative, scin-
tigraphically detected struma ovarii have been described in 
the literature. 
Case report
A 57 y/o Palauan female with a medical history of  
noninsulin-dependent diabetes mellitus, obesity, and 
exercise-induced asthma was referred to Tripler Army 
Medical Center (TAMC) for the evaluation of  an enlarging 
multinodular goiter (MNG) diagnosed by ultrasound (US). 
As she was initially euthyroid, she was started on low-dose 
synthroid for thyroid-stimulating hormone (TSH) suppres-
sion; however, she reported that the MNG continued to 
enlarge. She began experiencing tightness in her throat, 
difficulty breathing, weight gain, and fatigue, prompting 
followup US and clinical studies that confirmed continued 
growth. 
At TAMC, she denied compressive or hyper/hypothyroid 
symptoms. Although an increased incidence of  thyroid 
cancer is observed in Pacific Island females, the patient has 
no other known risk factors nor a family history of  thyroid 
cancer (8). Physical exam revealed a nontender, bilaterally 
enlarged thyroid gland with US findings of  MNG with the 
largest nodule exhibiting microcalcifications. The patient 
was counseled on management options, including total thy-
roidectomy vs. watchful waiting, and elected to proceed 
with surgery. Pre-operative free T4 (FT4) measured 
1.1ng/dL, and TSH was 1.232 uIU/mL.
Gross examination of  the removed specimen revealed an 
enlarged gland (R lobe: 4.7x3.3x3.1 cm, L lobe: 
4.8x2.7x2.6 cm, Isthmus 1.9x0.8x1.8 cm) with multiple, 
well-defined nodules and an area of  focal peripheral calcifi-
cation around the largest nodule. Histopathologic study 
found that the cytologic features of  papillary thyroid carci-
noma (nuclear clearing, grooves, nuclear enlargement, and 
overlap) were not uniform throughout the nodule, but fo-
cally present. The specimen was sent to the Armed Forces 
Institute of  Pathology for expert consultation. The final 
diagnosis was made of  a confined, 2.5-cm papillary thyroid 
carcinoma (follicular variant) with surrounding MNG and 
negative margins. 
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Figure 1. 57-year-old female with struma ovarii. Scintigraphic images ten days after the administration of 104.8 mCi I-
131 sodium iodide demonstrate (upper) a solitary focus of intensely increased radiotracer accumulation within the midline pel-
vis () and (lower) two small foci of radionuclide accumulation in the region of the thyroid bed () with an additional third 
focus of mildly increased uptake present in the region of the nasopharynx/maxilla, likely representing a mucous retention cyst 
(). The intense focus located in the midline pelvis (), resembling a six pointed star, is referred to as “star artifact” and oc-
curs when a high-energy radionuclide is concentrated within a small volume. (“<< SSN” and “<< XIPHOID” in the “ANT NECK 
W/MARK” and “ANT CHEST W/MARK” panes represent markers placed at the patientʼs suprasternal notch and xiphoid proc-
ess, respectively, and are used for anatomical orientation.)
Followup lab reports showed normal FT4 (0.9 ng/dL) 
and TSH (1.071 uIU/mL) but an elevated thyroglobulin 
(Tg) level measuring 335 ng/mL. Endocrinology offered 
the differential diagnosis for elevated Tg level as lab error, 
residual thyroid tissue, substernal extension of  adenomatoid 
MNG and/or metastatic thyroid cancer. Thyrogen (rTSH) 
stimulated I-131 therapy was recommended for remnant 
ablation. Subsequent lab results drawn prior to this therapy 
revealed an elevated FT4 (1.8 ng/dL), decreased TSH 
(0.049 uIU/mL), and an elevated but stable Tg (339 ng/
mL). 
The patient was admitted for thyrogen stimulation and 
was given a dose of  104.8 mCi I-131 sodium iodide, by 
mouth, two days later. In addition to residual iodine-avid 
tissue in the thyroid bed, postablation scans the following 
week revealed that within the midline pelvis, there was a so-
litary focus of intensely increased radiotracer accumulation 
with no other abnormal focal accumulations (Fig. 1). Meta-
static disease vs. struma ovarii was suggested as possible 
etiologies, and anatomic imaging was recommended. A 
right ovarian mass with mixed solid and cystic components 
was discovered by US in the corresponding vicinity of  in-
creased radiotracer uptake (Fig. 2). These findings were 
highly suggestive of  ectopic thyroid tissue, most likely 
struma ovarii. Given the patient's postmenopausal status, 
an exploratory laparotomy/bilateral salpingo-
oophorectomy and peritoneal washings were performed.
Gross examination of  the removed right ovarian mass 
revealed a 7.0x6.9x5.0-cm enlarged and multilobulated 
ovary filled with colloidal/gelatinous yellow-green material. 
Microscopic examination confirmed a mature teratoma 
with predominant benign thyroid component consistent 
with struma ovarii (Fig. 3). On postsurgical followup, FT4 
measured 1.6 ng /mL, TSH measured 0.055 uIU/mL, and 
Tg and Tg antibody levels were undetectable. Full TSH 
suppression was not recommended, given the low risk for 
reoccurrence in this patient. Tg levels would be used as a 
marker of  residual thyroid tissue, but aggressive thyroid 
cancer followup scanning was not advised given her low 
risk status. The patient was restarted on levothyroxine with 
a target TSH of  0.2-2.5 uIU/mL and has returned to Pa-
lau for regular followup. 
Discussion
Struma ovarii (SO) remains a rare preoperative diagnosis 
when considering ovarian teratomas and accounts for less 
than 3% of  confirmed lesions. Yoo et al. report that the 
most common presenting symptoms of  SO were a palpable 
lower abdominal mass (23.5%), followed by lower abdomi-
nal pain (20.6 %), and abnormal vaginal bleeding (8.8%). 
In a small minority of  cases, SO can also present as ascities, 
hydrothorax, elevated thyroid function, and rarely thyroid 
tumors. However, in 41.2% of  patients, no definite present-
ing symptoms were found (9). With only 3% to 8% of  pa-
tients presenting with hyperthyroid symptoms, clinicians 
may be left with little suspicion of  SO as an etiology (4). 
In the minority of  patients who are symptomatic, US is 
an ideal first choice for imaging, as it is readily available 
and does not use ionizing radiation. Unfortunately, Yoo et 
al. found that sonographic studies were able to correctly 
diagnose SO in only 11.8% of  patients (9). There also re-
mains difficulty in distinguishing between SO and dermoid 
cysts on the basis of  their sonographic appearance alone, 
although the characteristic findings of  teeth, bone, carti-
lage, and fatty material within a dermoid cyst can easily be 
seen with CT and MRI and may aid in the separation of  
the two diagnoses (2,10). Diagnostic images obtained by 
US, CT, and MRI can be similar to those seen in ovarian 
cancer, especially when marked thickening of  a peripheral 
cyst wall or septum is found (11). In addition, immature 
teratomas (malignant) and solid mature teratomas (benign) 
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Figure 2. 57-year-old female with struma ovarii. Sagittal 
(upper) and transverse (lower) sonographic images of the 
right adenexa demonstrate a large, mixed-solid and cys-
tic mass measuring 5.9 x 4.4 x 5.7 cm corresponding to the 
location of the increased radiotracer accumulation 
on the comparison nuclear medicine study. (“POST MEN 
1999” refers to the patient becoming postmenopausal in 
1999. “NO HTR” clarifies that the patient is not currently 
taking hormonal replacement therapy at the time of the 
study.)
share characteristic appearances on MR imaging that make 
them virtually indistinguishable (10). The often-
encountered nonspecific findings and unclear nature of  
these ovarian masses prompt the removal of  the lesion and 
lead to the postoperative diagnosis of  SO. It is in this man-
ner that the majority of  SO cases are diagnosed.
Scintigraphic I-131 whole-body scan (WBS) can be effec-
tive in the preoperative diagnosis of  SO; however, this study 
is reserved for patients with potential metastatic or recur-
rent differentiated thyroid carcinoma after total thyroidec-
tomy. The potential diagnostic capability of  I-131 in detect-
ing ectopic (SO) and malignant thyroid tissues was illus-
trated in studies by Fujie et al., reporting a sensitivity of  
61% and specificity of  98% for I-131 ablation and follow-
ing I-131 WBS in this patient population (12). Along with 
US, serial thyroid function tests, and serum Tg levels, I-131 
remains a cornerstone for the surveillance of  high-risk re-
current thyroid disease (13). With its restricted use, radia-
tion exposure, limited availability, and cost, I-131 is not an 
appropriate screening tool for SO. However, in our patient 
the I-131 ablation and WBS results proved to be the critical 
finding that raised our suspicion and eventually led to the 
pathologically confirmed diagnosis of  SO.
Scintigraphic Iodine-123 (I-123) WBS could represent an 
equally sensitive and lower-dose alternative to I-131 WBS 
as a potential exam for the preoperative confirmation of  
SO. The diagnostic indications of  I-123 are identical to 
those of  I-131. When compared with I-131, I-123’s shorter 
half-life (13.2 hours vs. 8.04 days), lack of  beta emission, 
and similar sensitivity make it a favorable isotope for the 
imaging of  thyroid tissue (14). The relative disadvantages of 
I-123 include lower availability, variable purity, and rela-
tively increased cost. In addition, the short half-life of  I-123 
prevents routine storage in some low-volume radiopharma-
cies, making advanced notice for imaging a necessity (14). 
Given the rarity of  SO, the utility of  scintigraphic screen-
ing is limited, but its high sensitivity makes it a viable op-
tion when pre-operative confirmation of  suspected SO is 
desired.
Considering the paucity of  symptoms, the restricted 
population of  patients eligible for scintigraphic studies and 
the nonspecific anatomic imaging findings, SO remains an 
incidental postoperative diagnosis (6). Since its first descrip-
tion in 1889, fewer than 500 cases of  SO have been re-
ported (15). To our knowledge, only two other cases of  an 
incidentally discovered SO following an I-131 whole-body 
scan after ablation for thyroid carcinoma have been re-
ported in the literature by Ghander et al. and MacDonald 
& Armstrong (6, 16). Our patient may represent only the 
third time that this rare presentation and diagnosis have 
been reported.
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